The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Omeprazole market was valued at US$ 2400.8 million in 2023 and is anticipated to reach US$ 3031.8 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
North American market for Omeprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Omeprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Omeprazole include AstraZeneca AB, Sandoz, Actavis, Teva, Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi, Mepha and Saval Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Omeprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Omeprazole.
Report Scope
The Omeprazole market size, estimations, and forecasts are provided in terms of sales volume (Kilotons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Omeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Omeprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca AB
Sandoz
Actavis
Teva
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi, Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
Segment by Type
Capsule
Tablet
Injection
Segment by Application
Children
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Omeprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Omeprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Omeprazole market was valued at US$ 2400.8 million in 2023 and is anticipated to reach US$ 3031.8 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
North American market for Omeprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Omeprazole is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Omeprazole include AstraZeneca AB, Sandoz, Actavis, Teva, Mylan, KernPharm, Garmish Pharmaceuticals, Sanofi, Mepha and Saval Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Omeprazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Omeprazole.
Report Scope
The Omeprazole market size, estimations, and forecasts are provided in terms of sales volume (Kilotons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Omeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Omeprazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca AB
Sandoz
Actavis
Teva
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi, Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
Segment by Type
Capsule
Tablet
Injection
Segment by Application
Children
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Omeprazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Omeprazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Omeprazole Market Overview
1.1 Product Overview and Scope of Omeprazole
1.2 Omeprazole Segment by Type
1.2.1 Global Omeprazole Market Value Comparison by Type (2024-2030)
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Injection
1.3 Omeprazole Segment by Application
1.3.1 Global Omeprazole Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Adult
1.4 Global Omeprazole Market Size Estimates and Forecasts
1.4.1 Global Omeprazole Revenue 2019-2030
1.4.2 Global Omeprazole Sales 2019-2030
1.4.3 Global Omeprazole Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Omeprazole Market Competition by Manufacturers
2.1 Global Omeprazole Sales Market Share by Manufacturers (2019-2024)
2.2 Global Omeprazole Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Omeprazole Average Price by Manufacturers (2019-2024)
2.4 Global Omeprazole Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Omeprazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Omeprazole, Product Type & Application
2.7 Omeprazole Market Competitive Situation and Trends
2.7.1 Omeprazole Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Omeprazole Players Market Share by Revenue
2.7.3 Global Omeprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Omeprazole Retrospective Market Scenario by Region
3.1 Global Omeprazole Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Omeprazole Global Omeprazole Sales by Region: 2019-2030
3.2.1 Global Omeprazole Sales by Region: 2019-2024
3.2.2 Global Omeprazole Sales by Region: 2025-2030
3.3 Global Omeprazole Global Omeprazole Revenue by Region: 2019-2030
3.3.1 Global Omeprazole Revenue by Region: 2019-2024
3.3.2 Global Omeprazole Revenue by Region: 2025-2030
3.4 North America Omeprazole Market Facts & Figures by Country
3.4.1 North America Omeprazole Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Omeprazole Sales by Country (2019-2030)
3.4.3 North America Omeprazole Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Omeprazole Market Facts & Figures by Country
3.5.1 Europe Omeprazole Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Omeprazole Sales by Country (2019-2030)
3.5.3 Europe Omeprazole Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Omeprazole Market Facts & Figures by Country
3.6.1 Asia Pacific Omeprazole Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Omeprazole Sales by Country (2019-2030)
3.6.3 Asia Pacific Omeprazole Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Omeprazole Market Facts & Figures by Country
3.7.1 Latin America Omeprazole Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Omeprazole Sales by Country (2019-2030)
3.7.3 Latin America Omeprazole Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Omeprazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Omeprazole Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Omeprazole Sales by Country (2019-2030)
3.8.3 Middle East and Africa Omeprazole Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Omeprazole Sales by Type (2019-2030)
4.1.1 Global Omeprazole Sales by Type (2019-2024)
4.1.2 Global Omeprazole Sales by Type (2025-2030)
4.1.3 Global Omeprazole Sales Market Share by Type (2019-2030)
4.2 Global Omeprazole Revenue by Type (2019-2030)
4.2.1 Global Omeprazole Revenue by Type (2019-2024)
4.2.2 Global Omeprazole Revenue by Type (2025-2030)
4.2.3 Global Omeprazole Revenue Market Share by Type (2019-2030)
4.3 Global Omeprazole Price by Type (2019-2030)
5 Segment by Application
5.1 Global Omeprazole Sales by Application (2019-2030)
5.1.1 Global Omeprazole Sales by Application (2019-2024)
5.1.2 Global Omeprazole Sales by Application (2025-2030)
5.1.3 Global Omeprazole Sales Market Share by Application (2019-2030)
5.2 Global Omeprazole Revenue by Application (2019-2030)
5.2.1 Global Omeprazole Revenue by Application (2019-2024)
5.2.2 Global Omeprazole Revenue by Application (2025-2030)
5.2.3 Global Omeprazole Revenue Market Share by Application (2019-2030)
5.3 Global Omeprazole Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca AB
6.1.1 AstraZeneca AB Corporation Information
6.1.2 AstraZeneca AB Description and Business Overview
6.1.3 AstraZeneca AB Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca AB Omeprazole Product Portfolio
6.1.5 AstraZeneca AB Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Corporation Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sandoz Omeprazole Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 Actavis
6.3.1 Actavis Corporation Information
6.3.2 Actavis Description and Business Overview
6.3.3 Actavis Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Actavis Omeprazole Product Portfolio
6.3.5 Actavis Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Omeprazole Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Omeprazole Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 KernPharm
6.6.1 KernPharm Corporation Information
6.6.2 KernPharm Description and Business Overview
6.6.3 KernPharm Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.6.4 KernPharm Omeprazole Product Portfolio
6.6.5 KernPharm Recent Developments/Updates
6.7 Garmish Pharmaceuticals
6.6.1 Garmish Pharmaceuticals Corporation Information
6.6.2 Garmish Pharmaceuticals Description and Business Overview
6.6.3 Garmish Pharmaceuticals Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Garmish Pharmaceuticals Omeprazole Product Portfolio
6.7.5 Garmish Pharmaceuticals Recent Developments/Updates
6.8 Sanofi, Mepha
6.8.1 Sanofi, Mepha Corporation Information
6.8.2 Sanofi, Mepha Description and Business Overview
6.8.3 Sanofi, Mepha Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi, Mepha Omeprazole Product Portfolio
6.8.5 Sanofi, Mepha Recent Developments/Updates
6.9 Saval Pharmaceutical
6.9.1 Saval Pharmaceutical Corporation Information
6.9.2 Saval Pharmaceutical Description and Business Overview
6.9.3 Saval Pharmaceutical Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Saval Pharmaceutical Omeprazole Product Portfolio
6.9.5 Saval Pharmaceutical Recent Developments/Updates
6.10 Stada
6.10.1 Stada Corporation Information
6.10.2 Stada Description and Business Overview
6.10.3 Stada Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Stada Omeprazole Product Portfolio
6.10.5 Stada Recent Developments/Updates
6.11 Blaskov
6.11.1 Blaskov Corporation Information
6.11.2 Blaskov Omeprazole Description and Business Overview
6.11.3 Blaskov Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Blaskov Omeprazole Product Portfolio
6.11.5 Blaskov Recent Developments/Updates
6.12 CQ Lummy
6.12.1 CQ Lummy Corporation Information
6.12.2 CQ Lummy Omeprazole Description and Business Overview
6.12.3 CQ Lummy Omeprazole Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CQ Lummy Omeprazole Product Portfolio
6.12.5 CQ Lummy Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Omeprazole Industry Chain Analysis
7.2 Omeprazole Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Omeprazole Production Mode & Process
7.4 Omeprazole Sales and Marketing
7.4.1 Omeprazole Sales Channels
7.4.2 Omeprazole Distributors
7.5 Omeprazole Customers
8 Omeprazole Market Dynamics
8.1 Omeprazole Industry Trends
8.2 Omeprazole Market Drivers
8.3 Omeprazole Market Challenges
8.4 Omeprazole Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Omeprazole Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Omeprazole Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Omeprazole Market Competitive Situation by Manufacturers in 2023
Table 4. Global Omeprazole Sales (Kilotons) of Key Manufacturers (2019-2024)
Table 5. Global Omeprazole Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Omeprazole Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Omeprazole Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Omeprazole Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Omeprazole, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Omeprazole, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Omeprazole, Product Type & Application
Table 12. Global Key Manufacturers of Omeprazole, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Omeprazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Omeprazole as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Omeprazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Omeprazole Sales by Region (2019-2024) & (Kilotons)
Table 18. Global Omeprazole Sales Market Share by Region (2019-2024)
Table 19. Global Omeprazole Sales by Region (2025-2030) & (Kilotons)
Table 20. Global Omeprazole Sales Market Share by Region (2025-2030)
Table 21. Global Omeprazole Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Omeprazole Revenue Market Share by Region (2019-2024)
Table 23. Global Omeprazole Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Omeprazole Revenue Market Share by Region (2025-2030)
Table 25. North America Omeprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Omeprazole Sales by Country (2019-2024) & (Kilotons)
Table 27. North America Omeprazole Sales by Country (2025-2030) & (Kilotons)
Table 28. North America Omeprazole Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Omeprazole Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Omeprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Omeprazole Sales by Country (2019-2024) & (Kilotons)
Table 32. Europe Omeprazole Sales by Country (2025-2030) & (Kilotons)
Table 33. Europe Omeprazole Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Omeprazole Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Omeprazole Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Omeprazole Sales by Region (2019-2024) & (Kilotons)
Table 37. Asia Pacific Omeprazole Sales by Region (2025-2030) & (Kilotons)
Table 38. Asia Pacific Omeprazole Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Omeprazole Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Omeprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Omeprazole Sales by Country (2019-2024) & (Kilotons)
Table 42. Latin America Omeprazole Sales by Country (2025-2030) & (Kilotons)
Table 43. Latin America Omeprazole Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Omeprazole Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Omeprazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Omeprazole Sales by Country (2019-2024) & (Kilotons)
Table 47. Middle East & Africa Omeprazole Sales by Country (2025-2030) & (Kilotons)
Table 48. Middle East & Africa Omeprazole Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Omeprazole Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Omeprazole Sales (Kilotons) by Type (2019-2024)
Table 51. Global Omeprazole Sales (Kilotons) by Type (2025-2030)
Table 52. Global Omeprazole Sales Market Share by Type (2019-2024)
Table 53. Global Omeprazole Sales Market Share by Type (2025-2030)
Table 54. Global Omeprazole Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Omeprazole Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Omeprazole Revenue Market Share by Type (2019-2024)
Table 57. Global Omeprazole Revenue Market Share by Type (2025-2030)
Table 58. Global Omeprazole Price (US$/Ton) by Type (2019-2024)
Table 59. Global Omeprazole Price (US$/Ton) by Type (2025-2030)
Table 60. Global Omeprazole Sales (Kilotons) by Application (2019-2024)
Table 61. Global Omeprazole Sales (Kilotons) by Application (2025-2030)
Table 62. Global Omeprazole Sales Market Share by Application (2019-2024)
Table 63. Global Omeprazole Sales Market Share by Application (2025-2030)
Table 64. Global Omeprazole Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Omeprazole Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Omeprazole Revenue Market Share by Application (2019-2024)
Table 67. Global Omeprazole Revenue Market Share by Application (2025-2030)
Table 68. Global Omeprazole Price (US$/Ton) by Application (2019-2024)
Table 69. Global Omeprazole Price (US$/Ton) by Application (2025-2030)
Table 70. AstraZeneca AB Corporation Information
Table 71. AstraZeneca AB Description and Business Overview
Table 72. AstraZeneca AB Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. AstraZeneca AB Omeprazole Product
Table 74. AstraZeneca AB Recent Developments/Updates
Table 75. Sandoz Corporation Information
Table 76. Sandoz Description and Business Overview
Table 77. Sandoz Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. Sandoz Omeprazole Product
Table 79. Sandoz Recent Developments/Updates
Table 80. Actavis Corporation Information
Table 81. Actavis Description and Business Overview
Table 82. Actavis Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Actavis Omeprazole Product
Table 84. Actavis Recent Developments/Updates
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Teva Omeprazole Product
Table 89. Teva Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Mylan Omeprazole Product
Table 94. Mylan Recent Developments/Updates
Table 95. KernPharm Corporation Information
Table 96. KernPharm Description and Business Overview
Table 97. KernPharm Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. KernPharm Omeprazole Product
Table 99. KernPharm Recent Developments/Updates
Table 100. Garmish Pharmaceuticals Corporation Information
Table 101. Garmish Pharmaceuticals Description and Business Overview
Table 102. Garmish Pharmaceuticals Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Garmish Pharmaceuticals Omeprazole Product
Table 104. Garmish Pharmaceuticals Recent Developments/Updates
Table 105. Sanofi, Mepha Corporation Information
Table 106. Sanofi, Mepha Description and Business Overview
Table 107. Sanofi, Mepha Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Sanofi, Mepha Omeprazole Product
Table 109. Sanofi, Mepha Recent Developments/Updates
Table 110. Saval Pharmaceutical Corporation Information
Table 111. Saval Pharmaceutical Description and Business Overview
Table 112. Saval Pharmaceutical Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Saval Pharmaceutical Omeprazole Product
Table 114. Saval Pharmaceutical Recent Developments/Updates
Table 115. Stada Corporation Information
Table 116. Stada Description and Business Overview
Table 117. Stada Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Stada Omeprazole Product
Table 119. Stada Recent Developments/Updates
Table 120. Blaskov Corporation Information
Table 121. Blaskov Description and Business Overview
Table 122. Blaskov Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Blaskov Omeprazole Product
Table 124. Blaskov Recent Developments/Updates
Table 125. CQ Lummy Corporation Information
Table 126. CQ Lummy Description and Business Overview
Table 127. CQ Lummy Omeprazole Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 128. CQ Lummy Omeprazole Product
Table 129. CQ Lummy Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Omeprazole Distributors List
Table 133. Omeprazole Customers List
Table 134. Omeprazole Market Trends
Table 135. Omeprazole Market Drivers
Table 136. Omeprazole Market Challenges
Table 137. Omeprazole Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Omeprazole
Figure 2. Global Omeprazole Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Omeprazole Market Share by Type in 2023 & 2030
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Injection Product Picture
Figure 7. Global Omeprazole Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Omeprazole Market Share by Application in 2023 & 2030
Figure 9. Children
Figure 10. Adult
Figure 11. Global Omeprazole Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Omeprazole Market Size (2019-2030) & (US$ Million)
Figure 13. Global Omeprazole Sales (2019-2030) & (Kilotons)
Figure 14. Global Omeprazole Average Price (US$/Ton) & (2019-2030)
Figure 15. Omeprazole Report Years Considered
Figure 16. Omeprazole Sales Share by Manufacturers in 2023
Figure 17. Global Omeprazole Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Omeprazole Players: Market Share by Revenue in 2023
Figure 19. Omeprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Omeprazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Omeprazole Sales Market Share by Country (2019-2030)
Figure 22. North America Omeprazole Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Omeprazole Sales Market Share by Country (2019-2030)
Figure 26. Europe Omeprazole Revenue Market Share by Country (2019-2030)
Figure 27. Germany Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Omeprazole Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Omeprazole Revenue Market Share by Region (2019-2030)
Figure 34. China Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Omeprazole Sales Market Share by Country (2019-2030)
Figure 45. Latin America Omeprazole Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Omeprazole Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Omeprazole Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Omeprazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Omeprazole by Type (2019-2030)
Figure 55. Global Revenue Market Share of Omeprazole by Type (2019-2030)
Figure 56. Global Omeprazole Price (US$/Ton) by Type (2019-2030)
Figure 57. Global Sales Market Share of Omeprazole by Application (2019-2030)
Figure 58. Global Revenue Market Share of Omeprazole by Application (2019-2030)
Figure 59. Global Omeprazole Price (US$/Ton) by Application (2019-2030)
Figure 60. Omeprazole Value Chain
Figure 61. Omeprazole Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
